Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

PERUSE investigators

doi:10.1093/annonc/mdz061

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

PERUSE investigators

Division of Internal Medicine (Medicine)

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	766-773
Number of pages	8
Journal	Annals of Oncology
Volume	30
Issue number	5
DOIs	https://doi.org/10.1093/annonc/mdz061
Publication status	Published - May 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

HER2-positive
dual HER2 blockade
First line
Metastatic breast cancer
Paclitaxel
Pertuzumab

Access to Document

10.1093/annonc/mdz061

Cite this

@article{12dbe0c85ffa462f931233e85b02b7e8,

title = "Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)",

keywords = "HER2-positive, dual HER2 blockade, First line, Metastatic breast cancer, Paclitaxel, Pertuzumab",

author = "\{PERUSE investigators\} and T. Bachelot and E. Ciruelos and A. Schneeweiss and F. Puglisi and T. Peretz-Yablonski and I. Bondarenko and S. Paluch-Shimon and A. Wardley and Merot, \{J. -L.\} and \{du Toit\}, Y. and V. Easton and N. Lindegger and D. Miles and Kamel Bouzid and Mario Campone and Bruno Coudert and Zbigniew Nowecki and Hassan Errihani and Florence Dalenc and Ana Ferreira and Max Mano and Francesco Ricci and Haralabos Kalofonos and Claudia Andreetta and Filippo Montemurro and Sophie Barrett and Qingyuan Zhang and Dimitris Mavroudis and Juan Matus and Carlos Beato and Xichun Hu and Rabab Gaafar and Azeem, \{Hamdy Abdel\} and Christophe Perrin and Johannes Ettl and Istvan Lang and Sunil Verma and Huiping Li and Etienne Brain and Oliver Hoffmann and Anna Cariello and Carlo Tondini and Taher Altwegeiri and Niklas Loman and Michael Lux and Antonio Frassoldati and Zeba Aziz and Fernando Salas and Joanna Streb and Sercan Aksoy",

year = "2019",

month = may,

doi = "10.1093/annonc/mdz061",

language = "English",

volume = "30",

pages = "766--773",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd",

number = "5",

}

TY - JOUR

T1 - Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

AU - PERUSE investigators

AU - Bachelot, T.

AU - Ciruelos, E.

AU - Schneeweiss, A.

AU - Puglisi, F.

AU - Peretz-Yablonski, T.

AU - Bondarenko, I.

AU - Paluch-Shimon, S.

AU - Wardley, A.

AU - Merot, J. -L.

AU - du Toit, Y.

AU - Easton, V.

AU - Lindegger, N.

AU - Miles, D.

AU - Bouzid, Kamel

AU - Campone, Mario

AU - Coudert, Bruno

AU - Nowecki, Zbigniew

AU - Errihani, Hassan

AU - Dalenc, Florence

AU - Ferreira, Ana

AU - Mano, Max

AU - Ricci, Francesco

AU - Kalofonos, Haralabos

AU - Andreetta, Claudia

AU - Montemurro, Filippo

AU - Barrett, Sophie

AU - Zhang, Qingyuan

AU - Mavroudis, Dimitris

AU - Matus, Juan

AU - Beato, Carlos

AU - Hu, Xichun

AU - Gaafar, Rabab

AU - Azeem, Hamdy Abdel

AU - Perrin, Christophe

AU - Ettl, Johannes

AU - Lang, Istvan

AU - Verma, Sunil

AU - Li, Huiping

AU - Brain, Etienne

AU - Hoffmann, Oliver

AU - Cariello, Anna

AU - Tondini, Carlo

AU - Altwegeiri, Taher

AU - Loman, Niklas

AU - Lux, Michael

AU - Frassoldati, Antonio

AU - Aziz, Zeba

AU - Salas, Fernando

AU - Streb, Joanna

AU - Aksoy, Sercan

PY - 2019/5

Y1 - 2019/5

KW - HER2-positive

KW - dual HER2 blockade

KW - First line

KW - Metastatic breast cancer

KW - Paclitaxel

KW - Pertuzumab

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=performanshacettepe&SrcAuth=WosAPI&KeyUT=WOS:000482490300012&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1093/annonc/mdz061

DO - 10.1093/annonc/mdz061

M3 - Article

SN - 0923-7534

VL - 30

SP - 766

EP - 773

JO - Annals of Oncology

JF - Annals of Oncology

IS - 5

ER -

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

UN SDGs

Keywords

Access to Document

Other files and links

Cite this